XI’AN, China, June 03, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced its board of directors approved a share repurchase program pursuant to which the Company may purchase up to $1.0 million of its Class A ordinary shares. Under the share repurchase program, the Company is authorized to repurchase its shares from time to time in the open market. The timing ...

Company enters option agreement with JiKang Therapeutics to in-license novel APJ agonist antibody New composition of matter IP filed for chemically distinct, orally active, and highly potent small molecule APJ agonists EMERYVILLE, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced advances in its apelin receptor ( ...

American Rebel Holdings, Inc AREB Total Wine and More Consumers looking for American Rebel Light – America’s Patriotic Beer can now purchase in-store at several Total Wine & More locations across the American Rebel Light Beer Distribution Footprint.Initial Placement for American Rebel Light Beer in either 12oz or 16oz cans is scheduled for 62 Total Wine & More Locations across 7 states.Total Wine & More has officially approved American Rebel Light Beer for immediate placement reinforcing the brand’s rap ...

Core Points - Dr. Nicholas Wernicki has been appointed as the new Dean of the Arts, Humanities, and Education School at American Public University System (APUS), effective May 22, 2025 [1][2] - Dr. Wernicki has extensive experience in academic leadership and workforce development, having held various roles at liberal arts colleges over the past decade [3] - He succeeds Dr. Michelle Newman, who served as Interim Dean, and joins a team of three other deans at APUS [4] Academic Background - Dr. Wernicki holds a Ph.D. in Philosophical and Theological Studies from Drew University, an M.Phil. in the same field, an M.A. in Liberal Studies from Villanova University, and a B.S. in Marketing from DeSales University [5] Institutional Overview - APUS has a 33-year history and a community of over 155,000 alumni from more than 80 countries, recognized for its innovative approach to online learning [6] - The institution is in the top 22% for students' return on educational investment among 4,396 colleges and universities nationwide, based on data from the Georgetown University Center on Education and the Workforce [6][8] - APUS is accredited by the Higher Learning Commission and is a wholly owned subsidiary of American Public Education, Inc. [7]

Company Overview - Proactive is a financial news publisher that provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The company has a team of experienced news journalists who produce independent content across key finance and investing hubs including London, New York, Toronto, Vancouver, Sydney, and Perth [2] Market Focus - Proactive specializes in medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [3] - The content delivered by the team includes insights across various sectors such as biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] Technology Adoption - Proactive is recognized for its forward-looking approach and enthusiastic adoption of technology to enhance workflows [4] - The company utilizes automation and software tools, including generative AI, while ensuring that all content is edited and authored by humans to maintain best practices in content production and search engine optimization [5]

Core Insights - Aeva Technologies (AEVA) has gained attention due to its partnership with Swiss delivery company Loxo, leveraging its unique GPS-free localization technology [1][9] - Aeva's 4D LiDAR sensor, Atlas, provides real-time velocity and direction data, distinguishing it from traditional LiDAR systems [2][6] - The technology is particularly beneficial for Loxo's expansion into dense European cities where GPS signals are often unreliable [3][9] Aeva's Distinctive Velocity Advantage - Aeva's Atlas sensor measures velocity and direction directly, offering a clear understanding of surroundings without GPS [2][6] - This capability is crucial for autonomous delivery vehicles operating in environments with weak GPS signals [3][6] Comparison with Competitors - Competitors like Luminar Technologies (LAZR) and Ouster (OUST) focus on high-resolution, long-range sensing but lack built-in velocity detection [4][5] - Luminar's Iris sensor estimates motion through software, which may introduce lag in real-time responsiveness, while Ouster relies on external data [5][6] Market Position and Valuation - Aeva's shares have surged approximately 265% year to date, indicating strong market interest [8] - The company trades at a forward price-to-sales ratio of 33.36, significantly higher than the sector average, and carries a Value Score of F [10] - The Zacks Consensus Estimate for Aeva's 2025 earnings suggests a 21% year-over-year improvement [11]

Core Insights - Equinor is advancing its Snohvit Future project to significantly reduce CO2 emissions from oil and gas production on the Norwegian continental shelf, aiming to meet Paris Agreement targets [1][2][9] Group 1: Project Overview - The Snohvit Future project, approved in August 2023, aims to halve oil and gas production emissions by 2030 compared to 2005 levels, targeting a reduction of 850,000 tons of CO2 emissions annually, which represents about 2% of Norway's total yearly emissions [2][5] - The project involves electrifying Hammerfest LNG with power from the mainland and implementing onshore compression to achieve these emissions reductions [2][5] Group 2: Construction and Implementation - The electrification initiative includes the installation of three large modules at Hammerfest LNG: a compressor, a transformer station, and electrode steam boilers [3] - A major tunnel is being constructed to carry power cables, and Statnett is building a new 420 kV line to meet increased power demand [3][5] - Onshore compression is expected to begin by 2028, with full electrification targeted for 2030, which will extend the life of the Snohvit field and maintain energy supply to Europe through 2050 [5][9] Group 3: Collaboration and Contracts - Axess Group has won an enterprise of competence contract with Aibel, reinforcing their collaboration on Equinor's carbon-reducing efforts at the Hammerfest LNG facility [1][4] - Aibel is leading modification work at the site and has commenced inspection and testing of over 250 pieces of lifting equipment on the compressor module [4][6]

Company Information - 74Software is an enterprise software group formed by the merger of Axway and SBS, specializing in mission-critical software for a data-driven world [3] - Axway has been a pioneer in enterprise integration solutions for 25 years, providing services to major brands and government agencies globally [3] - SBS focuses on empowering banks and financial institutions with a cloud-based architecture for various financial services [3] - The company serves over 11,000 clients, including more than 1,500 in the financial services sector [3] Voting Rights and Shares - As of May 31, 2025, the total number of shares is 29,746,194 [5] - The total number of theoretical voting rights is 41,294,970 [5] - The number of exercisable voting rights is 40,813,565, which includes shares with suspended voting rights [1]

Core Viewpoint - Eli Lilly (LLY) is positioned as a strong long-term investment opportunity in the obesity treatment market, particularly with its GLP-1 drugs, despite potential competition and earnings growth slowdown risks. Group 1: Market Performance and Resilience - Eli Lilly's stock has shown relative resilience compared to the broader market, with a 19% decline during the 2022 inflation shock and a 23% decline during the 2020 COVID-19 pandemic, while the S&P 500 experienced declines of 25% and 34% respectively [2] - LLY stock has already absorbed significant impacts, falling over 20% from its 52-week high of over $970 to below $750 [3] Group 2: Market Potential and Competitive Position - The market for GLP-1 drugs is projected to grow to $150 billion by 2030, with Eli Lilly and Novo Nordisk currently dominating, having generated over $40 billion in sales last year [3] - Eli Lilly is a leader in the obesity treatment race, with superior efficacy and multiple product offerings, including injectable Zepbound and promising oral GLP-1 formulations showing nearly 8% weight loss in trials [3] Group 3: Financial Performance and Stability - Eli Lilly's growth rate is accelerating at over 30%, significantly higher than AbbVie's under 5%, with a three-year average growth rate of 17% compared to AbbVie's less than 1% [6] - Eli Lilly's three-year average margins stand at 34%, superior to AbbVie's 26%, indicating better profitability [6] - Eli Lilly's balance sheet is stronger, with debt making up only 4% of equity compared to AbbVie's 20%, signaling a healthier financial standing [6]

Economic Indicators - UBS has identified that recession risks in the United States are increasing, with three main indicators showing concerning trends: real-world data, credit conditions, and the yield curve [1][2] - The probability of a US recession based on real-world data has risen to 46%, an increase of 12 percentage points in just one month, indicating broad-based weakness in key economic areas [4][3] - The yield curve currently suggests an 18% probability of recession, which, while lower than previous extremes, still represents a notable increase [5] Credit Conditions - UBS's credit-based model indicates a 48% probability of recession, marking the highest level since the pandemic, reflecting shifts in financial ratios and lending conditions [6] Composite Recession Risk - The composite gauge from UBS places the overall US recession risk at 37%, up from 26% in December, approaching levels historically associated with actual downturns [7] - Despite these indicators, UBS does not currently predict a recession, noting that the economy began the year on stable footing, but warns that further data deterioration could reignite recession discussions [7] Global Implications - The US consumer remains a critical driver of global demand, and any retrenchment in consumer spending or business investment could negatively impact the developed world [9] - The situation is being closely monitored, with upcoming data in May and June expected to influence market narratives significantly [10]